The HERA W10 Elite has updated imaging capabilities. Credit: Samsung.

Through its digital radiography and ultrasound business, Boston Imaging, Samsung has introduced a new women’s health ultrasound system, the Hera W10 Elite, which offers visualisation features, artificial intelligence (AI)-aided tools and clinical applications for Obstetrics and Gynecology.

As the premier model of the HERA platform, the HERA W10 Elite provides 2D and 3D visualisations of microcirculatory and slow blood.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The ultrasound system has been updated from its predecessor in various aspects.

It now features an Advanced MV-Flow feature and a larger organic light-emitting diode (OLED) display that provides improved characterisation of diverse ultrasound images.

Boston Imaging women’s health ultrasound business leader Tracy Bury said: “Women’s health is a fast-growing field that requires state-of-the-art equipment for patient care. The HERA W10 Elite will bring visionary change to Obstetrics and Gynecology with sophisticated image processing and an ergonomic-friendly design.”

See Also:

With its intuitive visualisations, precise analytic features and quick operation, the HERA W10 Elite is designed to provide greater diagnosis insight for clinicians.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the platform features a new transducer to allow visualisation of the fetal heart and brain endovaginally starting at eight weeks.

Enhanced AI features of the system include HeartAssist, ViewAssist and BiometryAssist.

The HeartAssist AI feature provides measurement results and can automatically classify an ultrasound image into measurement views that are needed for fetal heart diagnosis, while ViewAssist can classify ultrasound images and annotate structures to make measurement more convenient.

The BiometryAssist AI is designed to allow clinicians to measure parameters of fetal growth with a single click while still maintaining exam consistency.